| Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of … F Sivera, M Andrés, L Carmona, ASR Kydd, J Moi, R Seth, ... Annals of the rheumatic diseases 73 (2), 328-335, 2014 | 403 | 2014 |
| Th17 and Th22 cells in psoriatic arthritis and psoriasis H Benham, P Norris, J Goodall, MD Wechalekar, O FitzGerald, ... Arthritis research & therapy 15, 1-11, 2013 | 273 | 2013 |
| Colchicine for acute gout BJ McKenzie, MD Wechalekar, RV Johnston, N Schlesinger, ... Cochrane Database of Systematic Reviews 2021 (8), 2021 | 183* | 2021 |
| Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use SM Proudman, MJ James, LD Spargo, RG Metcalf, TR Sullivan, ... Annals of the rheumatic diseases 74 (1), 89-95, 2015 | 177 | 2015 |
| Non‐steroidal anti‐inflammatory drugs for acute gout CMPG van Durme, MD Wechalekar, R Buchbinder, N Schlesinger, ... Cochrane Database of Systematic Reviews, 2014 | 133 | 2014 |
| Colchicine for acute gout I van Echteld, MD Wechalekar, N Schlesinger, R Buchbinder, D Aletaha Cochrane database of systematic reviews, 2014 | 116 | 2014 |
| Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression Y Guo, AM Walsh, M Canavan, MD Wechalekar, S Cole, X Yin, B Scott, ... PloS one 13 (2), e0192704, 2018 | 110 | 2018 |
| Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus S Cole, A Walsh, X Yin, MD Wechalekar, MD Smith, SM Proudman, ... Arthritis research & therapy 20, 1-14, 2018 | 105 | 2018 |
| CD40L-dependent pathway is active at various stages of rheumatoid arthritis disease progression Y Guo, AM Walsh, U Fearon, MD Smith, MD Wechalekar, X Yin, S Cole, ... The Journal of Immunology 198 (11), 4490-4501, 2017 | 97 | 2017 |
| Interleukin‐1 inhibitors for acute gout F Sivera, MD Wechalekar, M Andrés, R Buchbinder, L Carmona Cochrane Database of Systematic Reviews, 2014 | 74 | 2014 |
| Australian and New Zealand recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion in the 3e Initiative SW Graf, SL Whittle, MD Wechalekar, JHY Moi, C Barrett, CL Hill, ... International journal of rheumatic diseases 18 (3), 341-351, 2015 | 70 | 2015 |
| Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement MD Wechalekar, S Lester, SM Proudman, LG Cleland, SL Whittle, ... Arthritis & Rheumatism 64 (5), 1316-1322, 2012 | 65 | 2012 |
| Intra‐articular glucocorticoids for acute gout MD Wechalekar, O Vinik, N Schlesinger, R Buchbinder Cochrane Database of Systematic Reviews, 2013 | 62 | 2013 |
| The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids … MD Wechalekar, O Vinik, JHY Moi, F Sivera, IAAM van Echteld, ... The Journal of Rheumatology Supplement 92, 15-25, 2014 | 57 | 2014 |
| Active Foot Synovitis in Patients with Rheumatoid Arthritis: Patients with Foot Synovitis in Apparent Remission have Unstable Remission Status, Radiographic Progression and … PSM Wechalekar MD, Lester S, Hill CL, Lee A, Rischmueller M, Smith MD, Walker JG Arthritis Care & Research, 2016 | 51* | 2016 |
| The novel cytokine Metrnl/IL-41 is elevated in psoriatic arthritis synovium and inducible from both entheseal and synovial fibroblasts C Bridgewood, T Russell, H Weedon, T Baboolal, A Watad, K Sharif, ... Clinical Immunology 208, 108253, 2019 | 47 | 2019 |
| Utility of arthroscopic guided synovial biopsy in understanding synovial tissue pathology in health and disease states MD Wechalekar, MD Smith World journal of orthopedics 5 (5), 566, 2014 | 43 | 2014 |
| Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways AM Walsh, MD Wechalekar, Y Guo, X Yin, H Weedon, SM Proudman, ... PLoS One 12 (9), e0183928, 2017 | 41 | 2017 |
| Treatment of asymptomatic hyperuricemia for the prevention of gouty arthritis, renal disease, and cardiovascular events: a systematic literature review O Vinik, MD Wechalekar, L Falzon, R Buchbinder, DM van der Heijde, ... The Journal of Rheumatology Supplement 92, 70-74, 2014 | 41 | 2014 |
| Factors associated with medication adherence in a longitudinal study of rheumatoid arthritis patients N Wabe, A Lee, M Wechalekar, L McWilliams, S Proudman, M Wiese International journal of clinical practice 73 (7), e13375, 2019 | 36 | 2019 |
